Kathmandu, Jan. 17 -- Last month, the prestigious New England Journal of Medicine published a study of the successful trial of a new typhoid vaccine that could prevent thedeaths of many children around the world. The vaccine research was conducted at Patan Hospital by a Nepali researcher.
The randomised control trial of the typhoid conjugate vaccine (TCV) was conducted among more than 20,000 participants in Lalitpur district, and the efficacy of the new vaccine was found to be 81.6% - a major improvement on previous vaccines. (See box below).
The positive news from Nepal came as various parts of the world, including the US, Europe, Samoa and Africa, struggled to cope with the biggest measles outbreak in decades. Most of the cases have now...